PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors
Published in Oncoimmunology, 2022
Use Google Scholar for full citation
Recommended citation: Anna Staniszewska, Joshua Armenia, Matthew King, Chrysiis Michaloglou, Avinash Reddy, Maneesh Singh, Maryann San, Laura Prickett, Zena Wilson, Theresa Proia, others, "'PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors.' Oncoimmunology, 2022.